GC
Gibson Christopher
OFFICERM
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Gibson Christopher. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 12 disclosures have been published. History available since 5 June 2026. The latest transaction was filed on 14 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Declarations12 total
100,000 shares@ US$3.3047Class ASEC144:0001959173-26-005224
100,000 shares@ US$3.43050.018% mcap2.9% of flowClass ASEC144:0001959173-26-005213
100,000 shares@ US$3.53580.019% mcap3.5% of flowClass ASEC144:0001959173-26-005195
286,000 shares@ US$3.79620.057% mcap12.1% of flowClass ASEC144:0001959173-26-005183
200,000 shares@ US$3.68850.039% mcap8.3% of flowClass ASEC144:0001959173-26-005163
250,000 shares@ US$3.950.052% mcap11.0% of flowClass ASEC144:0001959173-26-005141
100,000 shares@ US$3.780.020% mcap4.2% of flowClass ASEC144:0001959173-26-005116
100,000 shares@ US$3.7450.018% mcap6.5% of flowClass ASEC144:0001959173-26-005052
100,000 shares@ US$3.66630.019% mcap3.6% of flowClass ASEC144:0001959173-26-005037
40,000 shares@ US$3.180.0067% mcap1.1% of flowClass ASEC144:0001959173-26-004757
300,440 shares@ US$3.20310.051% mcap8.5% of flowClass ASEC144:0001959173-26-004782
40,000 shares@ US$3.620.0075% mcap1.2% of flowClass ASEC144:0001959173-26-004369
About Gibson Christopher
Gibson Christopher is a declarant linked to Recursion Pharmaceuticals, INC. as a former Director. Across 5 filings, all in the sampled period from 2026-07-02 to 2026-07-09, the reported activity consists of sales totaling EUR 3118115, and the modal transaction nature is a notice of proposed sale (Form 144).